Skin & hair

When Eczema Stops Answering to Treatment

Save

A cream that isn't working can mean several different things, and they call for different responses. This walks through why eczema stalls on treatment that should be working, how a dermatologist sorts technique problems from infection from genuinely severe disease, and where the eczema treatment ladder goes once topical steroids alone aren't holding the skin.

Last updated: July 2026History

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

Why "Not Working" Usually Isn't the First Diagnosis Being Wrong

Atopic dermatitis is a chronic condition driven by immune dysregulation and a weakened skin barrier, and it naturally flares and remits rather than resolving in a straight line, which is part of why a treatment that seems to be failing is often just being outpaced by a bad flare rather than genuinely not working 1. Before anything is escalated, the more common explanations are worth ruling out: not enough topical steroid being used, a potency mismatched to how thick the affected skin is, or moisturizer being applied inconsistently, since even a well-chosen regimen fails if it isn't actually reaching the skin at the frequency and amount it was prescribed for 2. Moisturizer alone measurably improves eczema outcomes, prolongs the time to the next flare, and reduces how much topical steroid is needed on top of it, so a bare-bones routine that skips it is already working with one hand tied 3.

Ruling Out Infection Before Assuming the Treatment Has Failed

Eczematous skin has a broken barrier and is frequently colonized with bacteria, so a flare that looks steroid-resistant is sometimes a secondary bacterial or viral infection layered on top of ordinary eczema rather than eczema itself getting worse 1. Signs that point toward infection rather than a plain flare include weeping, yellow crusting, pus-filled bumps, or skin that is suddenly far more painful than itchy — pain out of proportion to the itch is a pattern eczema alone doesn't usually produce. Because an infected flare generally needs an antibiotic or antiviral addition rather than a stronger steroid, distinguishing the two matters: treating an infection as if it were simply resistant eczema, by increasing steroid alone, tends to make things worse rather than better.

When the Diagnosis Is Right But the Disease Has Outgrown Topical Treatment

Once technique and infection are ruled out, some eczema genuinely is too extensive or too active for topical treatment alone to control, and that is a real category, not a failure of willpower or adherence. The adult eczema ladder moves through topical corticosteroids, topical calcineurin inhibitors, and other topical anti-inflammatory agents first, but guidelines recognize a point at which phototherapy or a systemic medicine is the appropriate next step rather than a stronger topical steroid indefinitely 2. That point is usually defined by how much body surface area is involved, how much the disease is disrupting sleep and daily function, and whether an adequate topical trial has already failed — not by a single bad week.

What the Eczema Systemic Options Actually Look Like

When eczema systemic options enter the conversation, dupilumab is often the first biologic discussed: in the trials that led to its approval, it improved signs, symptoms, itch, and quality of life in adults with moderate-to-severe atopic dermatitis whose disease wasn't controlled by topical therapy alone 4. Guidelines also cover oral JAK inhibitors and older systemic immunosuppressants as options in this tier, each with a different balance of how quickly they work, how they're monitored, and how they're taken 2. None of these is a decision made lightly or without monitoring, and which one fits best depends on other health conditions, how quickly relief is needed, and what a person can realistically manage in terms of follow-up and lab work — a conversation for a dermatologist to walk through, not something to sort out from a symptom description alone.

Steroid-Resistant Eczema: What the Term Actually Means

Steroid-resistant eczema describes disease that keeps flaring despite an adequately potent, adequately applied topical steroid — a real clinical category, not a description of every stubborn flare. Eczema not responding to steroid cream after a genuinely adequate trial is what pushes a clinician to consider whether the skin has developed reduced responsiveness to that particular drug class, whether an unaddressed trigger is continuously reintroducing the flare, or whether the disease was always going to need a topical calcineurin inhibitor or systemic option layered in rather than a stronger steroid. Refractory eczema escalation isn't a single next step so much as a structured reassessment — checking the diagnosis again, checking triggers again, and only then moving up the treatment ladder.

Phototherapy: The Step Between Topical and Systemic

Light therapy for eczema, most often narrowband UVB, sits between topical treatment and systemic medication on the ladder and is an option for people whose disease is too extensive for creams alone but who want to avoid or delay a systemic drug, or whose disease responds well to light 2. It requires a real time commitment — typically multiple visits a week to a clinic with the right equipment — which is its main practical drawback compared with a topical or a self-injected biologic. For some people that trade-off, more visits in exchange for avoiding a systemic medication, is worth it; for others whose schedule or distance from a phototherapy unit makes that impractical, a systemic option ends up being the more realistic path even if it wasn't the first choice.

What to Bring to the Next Appointment

A useful visit for eczema that isn't improving covers what's actually being applied, how often, and for how long, plus any new triggers, products, or exposures that started around the same time as the flare. Photos of the skin over the preceding weeks, rather than only how it looks on the day of the appointment, help a dermatologist see the actual pattern instead of a single snapshot that might catch a good day or a bad one. Bringing the specific product names and strengths already tried, rather than describing them from memory, also shortens the visit — a dermatologist reassessing eczema that hasn't improved is often retracing exactly this ground first before deciding whether the next step is a technique fix or a real escalation.

Common questions

Most topical regimens are expected to show visible improvement within two to four weeks when used correctly. If a properly potent steroid, applied as directed, hasn't improved the skin in that window, that is a reasonable point to have a dermatologist reassess rather than continuing to wait, since it may be technique, infection, or the disease itself outrunning that step.

Sometimes. A flare that suddenly stops matching the usual pattern — new pain out of proportion to itch, weeping or crusting, or a rash that looks different from prior flares — is worth having examined rather than assumed to be the same eczema simply getting worse, since infection and other skin conditions can mimic or complicate atopic dermatitis.

For a meaningful share of people with moderate-to-severe atopic dermatitis, yes — it is a recognized step on the treatment ladder, not a sign that earlier treatment failed or was managed poorly. Guidelines specifically address when phototherapy or a systemic drug becomes the appropriate next step rather than an indefinitely stronger topical regimen.

Both are systemic options for moderate-to-severe eczema not controlled by topicals, but they work through different mechanisms, have different monitoring requirements, and differ in how quickly they typically show effect. Which fits better depends on other health conditions and personal factors a dermatologist weighs directly rather than a general comparison being able to decide for any one person.

Yes, and it's one of the first things a dermatologist checks. Under-applying steroid, using a potency too low for thickened skin, or skipping moisturizer between steroid applications can all make an otherwise adequate treatment plan look like it's failing when the real issue is how it's being used.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When a Flare Needs Same-Day Attention

  • —Weeping, honey-colored crusting, or pus-filled bumps within eczema, which can signal a bacterial infection
  • —Clusters of painful blisters or punched-out sores, especially with fever, which can signal a viral skin infection
  • —Pain that is out of proportion to itch in an eczema flare
  • —Fever, chills, or spreading redness and warmth around the affected skin

Widespread painful blistering, fever with a worsening rash, or any rapidly spreading skin infection warrants same-day medical care — urgent care or the ER if symptoms are severe or the person appears seriously unwell.

This article is general health information, not medical advice. It cannot diagnose why a specific case of eczema isn't responding to treatment or replace an in-person evaluation by a dermatologist. Decisions about escalating eczema treatment should be made with the clinician managing that care.

Did this answer your question?

References

  1. 1.National Institute of Allergy and Infectious Diseases (2024). Eczema (Atopic Dermatitis). NIH / NIAID. link ✓Institutional overview supporting that atopic dermatitis is driven by immune dysregulation and skin-barrier dysfunction, follows a flare/remission course, and involves broken, frequently colonized skin — background for why a flare is not automatically the same as treatment failure.
  2. 2.Sidbury R, Davis DM, Alikhan A, et al. (2024). Guidelines of care for the management of atopic dermatitis in adults with phototherapy and systemic therapies. Journal of the American Academy of Dermatology. PMID 37943240AAD recommendations for phototherapy and systemic therapy (dupilumab, JAK inhibitors, traditional immunosuppressants) in adult atopic dermatitis, defining when disease has moved past an adequate topical trial into escalation territory.
  3. 3.van Zuuren EJ, Fedorowicz Z, Christensen R, et al. (2017). Emollients and moisturisers for eczema. Cochrane Database of Systematic Reviews. PMID 28432721 ✓Cochrane review supporting that moisturizers improve eczema outcomes, prolong time to flare, reduce number of flares, and reduce the amount of topical corticosteroid needed when combined with active treatment.
  4. 4.Simpson EL, Bieber T, Guttman-Yassky E, et al. (2016). Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. New England Journal of Medicine. doi:10.1056/NEJMoa1610020 ✓SOLO 1 and SOLO 2 phase 3 placebo-controlled trials showing dupilumab improves signs, symptoms, itch, and quality of life in adults with moderate-to-severe atopic dermatitis inadequately controlled by topical therapy.

4 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — citations link their sources. Editorial policy

← Back to the health library